MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Related Posts
Keykhaei M, Sandhu AT, Hsue PY, Greene SJ, Ziaeian B, Kittleson M, Villarreal-Gonzalez M, Hallaj S, Ramsis M, Agarwal MA, Fonarow GC. National Impact of[...]
Mak S, Ghadimi S, Der-McLeod E, Naeem S, Moore V, Gil L, Chohan M, Zeidler M, Ash G, Fung C. Feasibility, acceptability, and usability of[...]
Bracken SJ, Weber JM, Neely ML, Swaminathan AC, Palmer SM, Wilfong EM, Chauffe AD, Volkmann ER. Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic[...]